As of 30 April, Selarsdi is available and interchangeable in all presentations that correspond with Stelara.

Medicare and its enrollees incurred significantly higher costs when Stelara injections were covered under Part D, where patients self-administer the drug, compared to when the injections were ...

Do not try to inject STELARA® yourself until you or your caregiver have been shown how to inject STELARA® by your doctor or nurse.

In October 2024, Imuldosa received approval from the Food and Drug Administration based on data from the phase 3 Opportuniti ...

If your doctor decides that you or a caregiver may give your injections of STELARA ® at home, you should receive training on the right way to prepare and inject STELARA ®.

For the treatment of psoriatic arthritis, STELARA is administered as a 45 mg subcutaneous injection at weeks 0 and 4, and then every 12 weeks, thereafter. For patients with co-existent moderate to ...

The FDA has approved Stelara (ustekinumab injection, from Centocor Ortho Biotech), a monoclonal antibody, for the treatment of moderate to severe psoriasis in patients ≥18 years of age who are ...

Stelara: Dosage, Studies In the studies, 927 patients who had at least five tender and swollen joints, as well as other criteria, received Stelara injections.

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale ...

The Food and Drug Administration has approved Celltrion's Steqeyma (ustekinumab-stba), a biosimilar to Johnson & Johnson's Stelara (ustekinumab), for subcutaneous injection or intravenous infusion ...

Stelara: Dosage, Studies In the studies, 927 patients who had at least five tender and , as well as other criteria, received Stelara injections.